Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by REDDY, J. M.
Right arrow Articles by ZANEVELD, L. J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by REDDY, J. M.
Right arrow Articles by ZANEVELD, L. J. D.
Journal of Andrology, Vol 1, Issue 1 28-32, Copyright © 1980 by The American Society of Andrology

Role of Hyaluronidase in Fertilization: The Antifertility Activity of Myocrisin, a Nontoxic Hyaluronidase Inhibitor

JAKKIDI M. REDDY 1, CATHY JOYCE 1, AND LOURENS J. D. ZANEVELD 1

1 Departments of Physiology and Biophysics, and Obstetrics and Gynecology, College of Medicine, University of Illinois at the Medical Center, Chicago, Illinois

Myocrisin, a hyaluronidase inhibitor of low molecular weight, was tested for antifertility activity. In addition, the effect of myocrisin on penetration of the follicle cell layer by spermatozoa was studied. Myocrisin prevented the in vitro fertilization of capacitated mouse spermatozoa when these were added to intact oocytes. The inhibitor had no effect on sperm motility at the concentrations used for the in vitro fertilization tests, and did not inhibit the acrosome reaction of guinea pig spermatozoa. Myocrisin also had no effect on human acrosin. Fertility was not prevented when the myocrisin-treated spermatozoa were added to oocytes from which the follicle cell layer had been removed, showing that sperm hyaluronidase is essential specifically for sperm penetration through this ovum investment, at least in the case of the mouse. Myocrisin is approved for human use by the FDA and is a compound worth further in vivo evaluation as a contraceptive.

     Key words: myocrisin, hyaluronidase inhibitor, fertilization, contraception, acrosome reaction, acrosin

Submitted on June 14, 1979
Revised on July 31, 1979
Accepted on July 31, 1979




This article has been cited by other articles:


Home page
Hum ReprodHome page
K. Chaudhury, A.K. Bhattacharyya, and S.K. Guha
Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive
Hum. Reprod., August 1, 2004; 19(8): 1826 - 1830.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by The American Society of Andrology.